De novo methylation of CpG islands, which are generally not methylated on autosomal genes in normal cells, is one of the most common genomic alterations in human cancers. Focal hypermethylation occurs in parallel with a genome-wide demethylation during carcinogenesis. The aberrant methylation of CpG islands, if it occurs in promoter regions, contributes to the inactivation of tumor suppressor, growth regulatory and other cancer related genes. Epigenetic modification of CpG islands is now considered to be a significant contributor to gene inactivation during carcinogenesis. The objectives of this proposal are to take advantage of new technologies developed for the analysis of chromatin structural changes, quantitative DNA methylation analysis and siRNA technology to determine the underlying mechanisms responsible for altered methylation patterns in human cancer. Additionally, we will continue the characterization of a drug we have discovered (Zebularine) which shows promise as a selective inhibitor of DNA methylation in cancer but not in normal cells. We will focus our attention on four specific aims. Firstly, we will use a new inducible siRNA vector we have developed for the production of conditional gene knockouts to determine the effects of DNA methyltransferase enzymes and chromatin modifying enzymes on the rate of remethylation of CpG islands following a transient demethylation induced by DNA methylase inhibitors. Secondly, we will utilize a new fingerprinting technique we have developed to determine how histone modification including acetylation and methylation become differentially distributed when the genome reacts to an induced demethylation. Thirdly, we will study the role of methylation in potentially silencing two genes at one time in the bi-directional CpG island promoter associated with the hMLH1 gene. Finally, we will continue to define the mechanisms of action of zebularine, which appears to be preferentially incorporated into the DNA of cancer relative to normal cells. Once in DNA, it functions as a mechanism-based inhibitor of DNA methyltransferase and appears to show specificity for the DNMT1 enzyme. This drug is orally active and might possibly find use as a chemotherapeutic agent.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA082422-07
Application #
6890994
Study Section
Cancer Etiology Study Section (CE)
Program Officer
Okano, Paul
Project Start
1999-09-17
Project End
2009-04-30
Budget Start
2005-07-01
Budget End
2006-04-30
Support Year
7
Fiscal Year
2005
Total Cost
$426,730
Indirect Cost
Name
University of Southern California
Department
Biochemistry
Type
Schools of Medicine
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Mundbjerg, Kamilla; Chopra, Sameer; Alemozaffar, Mehrdad et al. (2017) Identifying aggressive prostate cancer foci using a DNA methylation classifier. Genome Biol 18:3
Lakshminarasimhan, Ranjani; Andreu-Vieyra, Claudia; Lawrenson, Kate et al. (2017) Down-regulation of ARID1A is sufficient to initiate neoplastic transformation along with epigenetic reprogramming in non-tumorigenic endometriotic cells. Cancer Lett 401:11-19
Helbo, Alexandra Søgaard; Lay, Fides D; Jones, Peter A et al. (2017) Nucleosome Positioning and NDR Structure at RNA Polymerase III Promoters. Sci Rep 7:41947
Charlet, Jessica; Duymich, Christopher E; Lay, Fides D et al. (2016) Bivalent Regions of Cytosine Methylation and H3K27 Acetylation Suggest an Active Role for DNA Methylation at Enhancers. Mol Cell 62:422-431
Jones, Peter A; Issa, Jean-Pierre J; Baylin, Stephen (2016) Targeting the cancer epigenome for therapy. Nat Rev Genet 17:630-41
Duymich, Christopher E; Charlet, Jessica; Yang, Xiaojing et al. (2016) DNMT3B isoforms without catalytic activity stimulate gene body methylation as accessory proteins in somatic cells. Nat Commun 7:11453
Becket, Elinne; Chopra, Sameer; Duymich, Christopher E et al. (2016) Identification of DNA Methylation-Independent Epigenetic Events Underlying Clear Cell Renal Cell Carcinoma. Cancer Res 76:1954-64
Baylin, Stephen B; Jones, Peter A (2016) Epigenetic Determinants of Cancer. Cold Spring Harb Perspect Biol 8:
Liu, Minmin; Ohtani, Hitoshi; Zhou, Wanding et al. (2016) Vitamin C increases viral mimicry induced by 5-aza-2'-deoxycytidine. Proc Natl Acad Sci U S A 113:10238-44
Roulois, David; Loo Yau, Helen; Singhania, Rajat et al. (2015) DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts. Cell 162:961-73

Showing the most recent 10 out of 59 publications